Sabra Health Care REIT (NASDAQ:SBRA) posted its quarterly earnings results on Wednesday. The real estate investment trust reported $0.57 EPS for the quarter, topping the consensus estimate of $0.30 by $0.27, Yahoo Finance reports. Sabra Health Care REIT had a net margin of 25.79% and a return on equity of 4.86%. The company had revenue of $166.47 million during the quarter, compared to analysts’ expectations of $158.82 million.
Shares of Sabra Health Care REIT (NASDAQ SBRA) traded up $0.25 during trading hours on Friday, hitting $17.32. 2,001,904 shares of the stock traded hands, compared to its average volume of 2,083,479. The stock has a market cap of $2,949.74, a P/E ratio of 18.16, a PEG ratio of 2.25 and a beta of 0.74. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.89. Sabra Health Care REIT has a twelve month low of $15.77 and a twelve month high of $29.10.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 28th. Stockholders of record on Thursday, February 15th will be given a dividend of $0.45 per share. The ex-dividend date is Wednesday, February 14th. This represents a $1.80 annualized dividend and a dividend yield of 10.39%. Sabra Health Care REIT’s dividend payout ratio is presently 191.49%.
In other news, Director Milton J. Walters sold 4,615 shares of the business’s stock in a transaction that occurred on Thursday, November 30th. The shares were sold at an average price of $19.18, for a total transaction of $88,515.70. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 2.60% of the stock is currently owned by insiders.
Several research analysts have commented on the stock. Stifel Nicolaus reiterated a “hold” rating and set a $22.00 price target on shares of Sabra Health Care REIT in a report on Friday, November 3rd. Raymond James Financial reiterated a “hold” rating on shares of Sabra Health Care REIT in a report on Wednesday, December 13th. TheStreet cut shares of Sabra Health Care REIT from a “b-” rating to a “c” rating in a report on Friday, November 3rd. SunTrust Banks reiterated a “buy” rating and set a $25.00 price target on shares of Sabra Health Care REIT in a report on Friday, November 3rd. Finally, Jefferies Group reiterated a “hold” rating on shares of Sabra Health Care REIT in a report on Thursday, December 21st. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and three have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $24.00.
WARNING: “Sabra Health Care REIT (SBRA) Issues Quarterly Earnings Results” was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this article on another domain, it was illegally copied and republished in violation of U.S. and international trademark and copyright law. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/02/23/sabra-health-care-reit-sbra-issues-quarterly-earnings-results.html.
About Sabra Health Care REIT
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.